Skip to main content

Table 1 The relationship between Annexin A2 expression levels and clinical characteristics of NSCLC patients

From: Annexin A2 contributes to cisplatin resistance by activation of JNK-p53 pathway in non-small cell lung cancer cells

Variables

Annexin A2

p Value

Low (n = 45)

High (n = 107)

Age

<60

21

55

0.387

≥60

24

52

Gender

Male

31

69

0.508

Female

14

38

Tumor size

<4 cm

18

37

0.212

≥4 cm

27

70

Histology

adenocarcinoma

25

59

0.276

squamous cell carcinoma

20

48

pTNM stage

I

19

12

0.012

II-IV

26

95

Lymph node metastasis

No

28

47

0.071

Yes

17

60

  1. p values listed are derived from χ2 test
Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us